Biomarkers as Clinical Trial Tools in AKI Studies

Time: 11:30 am
day: Seminar Day


  • Reviewing biomarker categories as they pertain to clinical trials
  • Analyzing biomarker candidates for early diagnostic and prognostic purposes in AKI trials
  • Facilitating earlier diagnosis of AKI and recognition of patients at risk of AKI, to slow disease progression